Sicad, Analuna I.
HRN: 01-28-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2025
CEFTRIAXONE 1G (VIAL)
04/02/2025
04/09/2025
IV
1g
Q12
T/C Acute Surgical Abdomen Prob Sec To Perforated Peptic Ulcer Disease
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes